Use of 99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy

European Journal of Nuclear Medicine

Volumn 24, Issue 5, 1997, Pages 511-515

  Soderlund V ^a   Larsson, S A ^a   Bauer, H C F ^a   Brosjo O ^a   Larsson, O ^a   Jacobsson, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemotherapy; Osteosarcoma; Technetium 99m hexakis 2 methoxyisobutylisonitrile; Therapy evaluation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HISTOLOGY; HUMAN; MALE; NECROSIS; OSTEOSARCOMA; PREOPERATIVE TREATMENT; SCHOOL CHILD; SCINTIGRAPHY; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BONE TUMOR; CHILD; LIMB; MIDDLE AGED; SCINTISCANNING;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; EXTREMITIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; TECHNETIUM TC 99M SESTAMIBI;

EID: 0030612452     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050083     Document Type: Article

References (28)

1. Sæter G. Treatment of bone and soft tissue sarcomas. Consultant series No. 15. Macclesfield: Gardiner-Caldwell Communications; 1996: 1-82.
2. Smith J, Heelan RT, Huvos AG, et al. Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiology 1982; 143: 355-360.
3. Erlemann R, Sciuk J, Bosse et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 1990; 175: 791-796.
4. Holscher HC, Bloem JL, Vanel D, et al. Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology 1992; 182: 839-844.
5. de Baere T, Vanel D, Shapeero LG, et al. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992; 185: 587-592.
6. Erlemann R, Reiser MF, Peters PE, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989; 171: 767-773.
7. van der Woude HJ, Bloem JL, Holscher HC, et al. Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging. Skeletal Radiol 1994; 23: 493-500.
8. van der Woude HJ, Bloem JL, Schipper J, et al. Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy. Radiology 1994; 191: 421-431.
9. van der Woude HJ, Bloem JL, van Oostayen JA, et al. Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of squential color Doppler sonography in predicting histopathological response. AJR 1995; 165: 125-133.
10. van der Woude HJ, Bloem JL, Verstraete KL, et al. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR 1995; 165: 593-598.
11. Ramanna L, Waxman AD, Waxman S, et al. Tl-201 (Tl) scintigraphy in bone and soft tissue sarcoma: evaluation of tumor mass and viability. J Nucl Med 1988; 29: 854P.
12. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990; 31: 567-572.
13. Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tisue sarcoma. J Bone Joint Surg [Am] 1993; 75: 526-531.
14. Rosen G, Loren GJ, Brien EW, et al. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis atter preoperative chemotherapy. Clin Orthop Rel Res 1993; 293: 302-306.
15. Lin J, Leung W, Ho SKW, et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995; 22: 553-555.
16. Jones AG, Abrams MJ, Davison A, et al. A. Biological studies of a new class of technetium complexes: the hexakis (alkylisonitrile) technetium (I) cation. Int J Nucl Med Biol 1984; 11: 225-234.
17. Gerundini P, Savi A, Gilardi MC, et al. Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agents. J Nucl Med 1986; 27: 409-416.
18. Bagni B, Pinna L, Tamarozzi R, et al. SPET imaging of intracranial tumours with 99Tcm-sestamibi. Nucl Med Commun 1995; 16: 258-264.
19. Khalkali I, Cutrone JA, Mena IG, et al. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995, 196: 421-426.
20. Kao CH, Wang SJ, Chen CT, Yeh SH. Detection of esophageal carcinoma using Tc-99m MIBI SPECT imaging. Clin Nucl Med 1994; 19: 1069-1074.
21. Ziegels P, Nocaudie M, Huglo D, et al. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas. Eur J Nucl Med 1995; 22: 126-131.
22. Picci P, Bacci G, Campanacci M, et al. Histological evaluation of necrosis in osteosarcoma induced by chemotherapy: regional mapping of viable and nonviable tumour. Cancer 1985; 56: 1515-1521.
23. Chiu ML, Kronauge JF, Piwnicka-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis(2-methoxy-isobutylisonitrile)technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
24. Nordenström B. Electric potentials in pulmonary lesions. A preliminary report. Acta Radiol [Diagn] 1971: 11: 1-16.
25. Nagaraj N, Ashok G, Waxman A, et al. Clinical usefulness of serial Tc-99m sestamibi (MIBI) scintigraphy in evaluating tumor response to preoperative chemotherapy in patients with bone and soft tissue sarcomas. J Nucl Med 1995; 36: 129P.
26. Kabasakal L, Özker K, Hayward M, et al. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug resistance. Eur J Nucl Med 1996; 23: 568-570.
27. Cordobes MD, Starzec A, Delmon-Moingeon L, et al. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996; 37: 286-289.
28. Mariani G. Unexpected keys in cell biochemistry imaging: some lessons from technetium-99m-sestamibi. J Nucl Med 1996; 37: 536-538.